|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005936 USD | -1.07% |
|
-1.67% | -26.25% |
| 06-18 | Petros Pharmaceuticals, Inc. Announces Executive Changes, Effective June 18, 2026 | CI |
| 06-18 | Petros Pharmaceuticals, Inc. Announces Principal Financial Officer Changes, Effective June 18, 2026 | CI |
Company Valuation: Petros Pharmaceuticals
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 42.71 | 68.71 | 4.825 | 3.103 | 3.945 | 0.3362 |
| Change | - | 60.87% | -92.98% | -35.68% | 27.11% | -91.48% |
| Enterprise Value (EV) 1 | 33.39 | 45.4 | 5.281 | -1.957 | 7.621 | -4.801 |
| Change | - | 35.97% | -88.37% | -137.05% | 489.45% | -162.99% |
| P/E | -1.14x | -4.04x | -0.24x | -0.22x | -0.12x | -0.01x |
| PBR | 2.45x | 1.94x | 0.29x | 0.35x | -0.56x | 0.12x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0x |
| Capitalization / Revenue | 4.47x | 8.8x | 0.81x | 0.53x | 0.77x | - |
| EV / Revenue | 3.49x | 5.81x | 0.88x | -0.34x | 1.49x | - |
| EV / EBITDA | -3.14x | -4.06x | -0.52x | 0.26x | -1.02x | 2.65x |
| EV / EBIT | -1.93x | -2.52x | -0.33x | 0.18x | -0.74x | 1.03x |
| EV / FCF | -7.33x | -9.08x | -0.2x | 1.41x | 5.87x | 0.38x |
| FCF Yield | -13.6% | -11% | -512% | 70.9% | 17% | 266% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -963.6 | -206.3 | -242 | -158.7 | -83.47 | -1.557 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 9.559 | 7.811 | 5.992 | 5.822 | 5.112 | - |
| EBITDA 1 | -10.62 | -11.17 | -10.25 | -7.479 | -7.465 | -1.81 |
| EBIT 1 | -17.28 | -18.05 | -15.85 | -10.76 | -10.3 | -4.641 |
| Net income 1 | -20.59 | -8.987 | -20.04 | -8.163 | -14.32 | 1.914 |
| Net Debt 1 | -9.325 | -23.32 | 0.4565 | -5.06 | 3.676 | -5.137 |
| Reference price 2 | 1,100.000000 | 832.500000 | 58.250000 | 35.250000 | 9.847500 | 0.007950 |
| Nbr of stocks (in thousands) | 38.8 | 82.5 | 82.8 | 88 | 401 | 42,285 |
| Announcement Date | 3/31/21 | 3/31/22 | 3/31/23 | 4/1/24 | 3/31/25 | 4/15/26 |
1USD in Million2USD
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- PTPI Stock
- Valuation Petros Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
